Community
Collaboration
CDD aims to help scientists optimally select and advance novel drug discovery candidates.
The CDD database advances this goal in several ways:
- CDD’s unique collaboration features enable scientists to build highly-networked virtual drug discovery and development communities.
- A focus on security, privacy, and selective sharing respects and protects intellectual property rights, which are essential to commercialize drugs.
- The software bridges the disciplines of biology, chemistry, computational chemistry, and medicinal chemistry, equipping globally dispersed efforts with the tools they need to combine complementary areas of expertise.
- Scientists can build deep technical collaborations that extend beyond exchanging data.
Neglected Diseases
The first CDD community has focused on drug discovery for neglected infectious diseases that disproportionately afflict the developing world. This community has access to multiple open-access databases on neglected infectious diseases. These include research data curated by CDD from the scientific literature as well as data shared openly and directly from the laboratories of leading scientists working on African Sleeping Sickness, Chagas Disease, Leishmaniasis, Malaria, Schistosomiasis, Tuberculosis and related infectious diseases.
Additional CDD communities are emerging in diverse research areas of commercial interest, such as cancer research. Each community has tools and content relevant to its specific topic.
Related Information:
- Buruli Ulcer
- Cholera
- Dengue/dengue haemorrhagic fever
- Dracunculiasis (guinea-worm disease)
- Leprosy
- Lymphatic filariasis
- Onchocerciasis
- Soil-transmitted helminthiases